Anixa Biosciences Inc (ANIX): EPS (Basic)
-$0.34
Year ended 2025-10-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-10-31 | -$0.34 | n/m | 2026-01-12, From 2024-11-01 |
| 2024-10-31 | -$0.39 | n/m | 2026-01-12, From 2023-11-01 |
| 2023-10-31 | -$0.32 | n/c | 2025-01-10, From 2022-11-01 |
| 2022-10-31 | $0.45 | n/c | 2024-01-16, From 2021-11-01 |
| 2021-10-31 | -$0.45 | n/a | 2023-01-04, From 2020-11-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | 2025-10-31 | -$0.34 | n/m |
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | -$1.93 | n/m |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 2025-12-31 | -$5.48 | n/m |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$1153.83 | n/m |
| Synlogic, Inc. (SYBX) | 2025-12-31 | -$0.08 | n/m |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | -$6.33 | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$1.77 | n/a |
| Cingulate Inc. (CING) | 2025-12-31 | -$4.44 | n/m |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | -$8.35 | n/m |
Compare ANIX, APRE, RVPH, ADTX side by side · Screen every company in Pharmaceutical Preparations ↗